Viatris (VTRS) EPS (Diluted) Growth (1y) (2020 - 2026)
Powered by 
Analysis
Viatris (VTRS) EPS (Diluted) Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn | -304.28% |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | -2,504.14% |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -71.69% |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn | 92.07% |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn | 100.44% |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn | 181.09% |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | 6.43% |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn | 147.53% |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,504.14% |
| Mar 31, 2026 | 105.88% |
| Dec 31, 2025 | 32.13% |
| Sep 30, 2025 | -239.39% |
| Jun 30, 2025 | 98.57% |
| Mar 31, 2025 | -2,809.06% |
| Dec 31, 2024 | 32.17% |
| Sep 30, 2024 | -71.24% |
| Jun 30, 2024 | -224.92% |
| Mar 31, 2024 | -49.47% |
| Dec 31, 2023 | -176.37% |
| Sep 30, 2023 | -5.59% |
| Jun 30, 2023 | -14.95% |
| Mar 31, 2023 | -43.36% |
| Dec 31, 2022 | 480.61% |
| Sep 30, 2022 | 13.23% |
| Jun 30, 2022 | 211.66% |
| Mar 31, 2022 | 138.30% |
| Dec 31, 2021 | 85.67% |
| Sep 30, 2021 | 178.62% |